OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(6)
Publication Date
Release Date
2025
(2)
2024
(1)
2023
(1)
2016
(1)
2022
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Real-world treatments and clinical outcomes in unfit AML patients receiving first-line treatment or best supportive care in Italy (CURRENT study).
Not available
S-EPMC11258386
|
biostudies-literature
Cite
c-Maf enforces cytokine production and promotes memory-like responses in mouse and human type 2 Innate Lymphoid Cells
Not available
S-SCDT-EMBOJ-2021-109300
|
biostudies-other
Cite
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.
Not available
S-EPMC12672642
|
biostudies-literature
Cite
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.
Not available
S-EPMC12584038
|
biostudies-literature
Cite
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts : National Harbor, MD, USA. 9-13 November 2016
Not available
S-EPMC5260784
|
biostudies-literature
Cite
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Not available
S-EPMC10794000
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets